Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco
- PMID: 2793232
- DOI: 10.1002/ijc.2910440408
Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco
Abstract
Relationships between risk of bladder cancer and tobacco smoking were assessed from a hospital-based case-control study conducted in France from 1984 to 1987. Smoking history was analyzed for 954 male patients (477 cases and 477 controls). The odds ratio (OR) of bladder cancer was estimated at 3.95 for all smokers vs. non-smokers. The risk increased with duration of smoking and with average daily cigarette consumption, but there was a significant interaction between these 2 parameters, since the risk only increased with average daily consumption when the duration exceeded 20 years. Black tobacco consumption and inhaling were both found to double the risk when analyzed separately, but their respective effects appeared to interact, and an elevated risk for smokers of black tobacco was only observed among inhalers. Smokers of black and blond tobacco also differed in the way in which the risk evolved with time after cessation of smoking. The OR decreased faster after cessation of smoking among smokers of black tobacco than among smokers of blond tobacco, but the residual risk was higher 15 years after cessation among the former than among the latter.
Similar articles
-
Bladder cancer and black tobacco cigarette smoking. Some results from a French case-control study.Eur J Epidemiol. 1994 Oct;10(5):599-604. doi: 10.1007/BF01719579. Eur J Epidemiol. 1994. PMID: 7859861
-
Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender.Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1348-54. doi: 10.1158/1055-9965.EPI-06-0021. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16835335
-
Tobacco smoke inhalation pattern, tobacco type, and bladder cancer in Spain.Am J Epidemiol. 1991 Oct 15;134(8):830-9. doi: 10.1093/oxfordjournals.aje.a116158. Am J Epidemiol. 1991. PMID: 1951278 Clinical Trial.
-
Black (air-cured) and blond (flue-cured) tobacco and cancer risk. I: Bladder cancer.Eur J Cancer. 1991;27(11):1491-3. doi: 10.1016/0277-5379(91)90038-f. Eur J Cancer. 1991. PMID: 1835867 Review.
-
Tobacco smoking and risk of bladder cancer.Scand J Urol Nephrol Suppl. 2008 Sep;(218):45-54. doi: 10.1080/03008880802283664. Scand J Urol Nephrol Suppl. 2008. PMID: 18815916 Review.
Cited by
-
Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder.PLoS One. 2011 Jan 19;6(1):e16209. doi: 10.1371/journal.pone.0016209. PLoS One. 2011. PMID: 21283818 Free PMC article.
-
Variation of keratin 7 expression and other phenotypic characteristics of independent isolates of cadmium transformed human urothelial cells (UROtsa).Chem Res Toxicol. 2010 Feb 15;23(2):348-56. doi: 10.1021/tx900346q. Chem Res Toxicol. 2010. PMID: 19921857 Free PMC article.
-
Cigarette smoking and risk of bladder cancer: a dose-response meta-analysis.Int Urol Nephrol. 2022 Jun;54(6):1169-1185. doi: 10.1007/s11255-022-03173-w. Epub 2022 Mar 25. Int Urol Nephrol. 2022. PMID: 35332429 Review.
-
Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer.Oncotarget. 2014 Nov 30;5(22):11209-24. doi: 10.18632/oncotarget.2026. Oncotarget. 2014. PMID: 25526030 Free PMC article.
-
Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.Oncol Rep. 2010 Jul;24(1):257-62. doi: 10.3892/or_00000854. Oncol Rep. 2010. PMID: 20514470 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical